nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—CYP2D6—Niacin—atherosclerosis	0.181	0.3	CbGbCtD
Nebivolol—CYP2D6—Simvastatin—atherosclerosis	0.143	0.237	CbGbCtD
Nebivolol—CYP2D6—Lovastatin—atherosclerosis	0.14	0.232	CbGbCtD
Nebivolol—CYP2D6—Pravastatin—atherosclerosis	0.14	0.232	CbGbCtD
Nebivolol—High density lipoprotein decreased—Niacin—atherosclerosis	0.0279	0.0866	CcSEcCtD
Nebivolol—Renal failure acute—Rosuvastatin—atherosclerosis	0.00605	0.0188	CcSEcCtD
Nebivolol—Renal failure acute—Pravastatin—atherosclerosis	0.00433	0.0135	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00418	0.013	CcSEcCtD
Nebivolol—Erectile dysfunction—Lovastatin—atherosclerosis	0.00377	0.0117	CcSEcCtD
Nebivolol—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00369	0.0115	CcSEcCtD
Nebivolol—Erectile dysfunction—Simvastatin—atherosclerosis	0.00352	0.0109	CcSEcCtD
Nebivolol—Mental disorder—Rosuvastatin—atherosclerosis	0.00338	0.0105	CcSEcCtD
Nebivolol—Erectile dysfunction—Niacin—atherosclerosis	0.00323	0.01	CcSEcCtD
Nebivolol—Erectile dysfunction—Pravastatin—atherosclerosis	0.00318	0.00989	CcSEcCtD
Nebivolol—Oedema peripheral—Ezetimibe—atherosclerosis	0.00316	0.00982	CcSEcCtD
Nebivolol—Angioedema—Rosuvastatin—atherosclerosis	0.00307	0.00954	CcSEcCtD
Nebivolol—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00304	0.00944	CcSEcCtD
Nebivolol—Myocardial infarction—Pravastatin—atherosclerosis	0.00302	0.00939	CcSEcCtD
Nebivolol—Mental disorder—Ezetimibe—atherosclerosis	0.00281	0.00873	CcSEcCtD
Nebivolol—Malnutrition—Ezetimibe—atherosclerosis	0.00279	0.00868	CcSEcCtD
Nebivolol—Oedema peripheral—Niacin—atherosclerosis	0.00277	0.0086	CcSEcCtD
Nebivolol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00269	0.00836	CcSEcCtD
Nebivolol—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00269	0.00834	CcSEcCtD
Nebivolol—Mental disorder—Simvastatin—atherosclerosis	0.00268	0.00833	CcSEcCtD
Nebivolol—Angioedema—Lovastatin—atherosclerosis	0.0026	0.00809	CcSEcCtD
Nebivolol—Cardiac disorder—Pravastatin—atherosclerosis	0.00257	0.00798	CcSEcCtD
Nebivolol—Vertigo—Lovastatin—atherosclerosis	0.00256	0.00795	CcSEcCtD
Nebivolol—Angioedema—Ezetimibe—atherosclerosis	0.00255	0.00793	CcSEcCtD
Nebivolol—Insomnia—Rosuvastatin—atherosclerosis	0.00248	0.00771	CcSEcCtD
Nebivolol—Paraesthesia—Rosuvastatin—atherosclerosis	0.00246	0.00765	CcSEcCtD
Nebivolol—Malnutrition—Niacin—atherosclerosis	0.00245	0.0076	CcSEcCtD
Nebivolol—Angioedema—Simvastatin—atherosclerosis	0.00244	0.00756	CcSEcCtD
Nebivolol—Chest pain—Lovastatin—atherosclerosis	0.00243	0.00753	CcSEcCtD
Nebivolol—Vertigo—Simvastatin—atherosclerosis	0.00239	0.00744	CcSEcCtD
Nebivolol—Chest pain—Ezetimibe—atherosclerosis	0.00238	0.00739	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00236	0.00734	CcSEcCtD
Nebivolol—Thrombocytopenia—Lovastatin—atherosclerosis	0.00228	0.00707	CcSEcCtD
Nebivolol—Chest pain—Simvastatin—atherosclerosis	0.00227	0.00705	CcSEcCtD
Nebivolol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00224	0.00697	CcSEcCtD
Nebivolol—Nervous system disorder—Ezetimibe—atherosclerosis	0.00224	0.00695	CcSEcCtD
Nebivolol—Angioedema—Niacin—atherosclerosis	0.00224	0.00694	CcSEcCtD
Nebivolol—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00223	0.00694	CcSEcCtD
Nebivolol—Skin disorder—Ezetimibe—atherosclerosis	0.00222	0.00688	CcSEcCtD
Nebivolol—Angioedema—Pravastatin—atherosclerosis	0.0022	0.00684	CcSEcCtD
Nebivolol—Vertigo—Niacin—atherosclerosis	0.0022	0.00683	CcSEcCtD
Nebivolol—Syncope—Niacin—atherosclerosis	0.00219	0.00682	CcSEcCtD
Nebivolol—Urticaria—Rosuvastatin—atherosclerosis	0.00218	0.00677	CcSEcCtD
Nebivolol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00217	0.00674	CcSEcCtD
Nebivolol—Vertigo—Pravastatin—atherosclerosis	0.00216	0.00672	CcSEcCtD
Nebivolol—Loss of consciousness—Niacin—atherosclerosis	0.00215	0.00668	CcSEcCtD
Nebivolol—Thrombocytopenia—Simvastatin—atherosclerosis	0.00213	0.00661	CcSEcCtD
Nebivolol—Insomnia—Lovastatin—atherosclerosis	0.0021	0.00653	CcSEcCtD
Nebivolol—Paraesthesia—Lovastatin—atherosclerosis	0.00209	0.00648	CcSEcCtD
Nebivolol—Dyspnoea—Lovastatin—atherosclerosis	0.00207	0.00644	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00207	0.00643	CcSEcCtD
Nebivolol—Insomnia—Ezetimibe—atherosclerosis	0.00206	0.00641	CcSEcCtD
Nebivolol—Chest pain—Pravastatin—atherosclerosis	0.00205	0.00637	CcSEcCtD
Nebivolol—Paraesthesia—Ezetimibe—atherosclerosis	0.00205	0.00636	CcSEcCtD
Nebivolol—Dyspnoea—Ezetimibe—atherosclerosis	0.00203	0.00632	CcSEcCtD
Nebivolol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00202	0.00628	CcSEcCtD
Nebivolol—Fatigue—Lovastatin—atherosclerosis	0.002	0.00623	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00197	0.00612	CcSEcCtD
Nebivolol—Asthenia—Rosuvastatin—atherosclerosis	0.00197	0.00611	CcSEcCtD
Nebivolol—Insomnia—Simvastatin—atherosclerosis	0.00197	0.00611	CcSEcCtD
Nebivolol—Fatigue—Ezetimibe—atherosclerosis	0.00197	0.00611	CcSEcCtD
Nebivolol—Shock—Niacin—atherosclerosis	0.00196	0.0061	CcSEcCtD
Nebivolol—Paraesthesia—Simvastatin—atherosclerosis	0.00195	0.00607	CcSEcCtD
Nebivolol—Pruritus—Rosuvastatin—atherosclerosis	0.00194	0.00603	CcSEcCtD
Nebivolol—Skin disorder—Niacin—atherosclerosis	0.00194	0.00602	CcSEcCtD
Nebivolol—Dyspnoea—Simvastatin—atherosclerosis	0.00194	0.00602	CcSEcCtD
Nebivolol—Thrombocytopenia—Pravastatin—atherosclerosis	0.00193	0.00598	CcSEcCtD
Nebivolol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.0019	0.00591	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00188	0.00583	CcSEcCtD
Nebivolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.00188	0.00583	CcSEcCtD
Nebivolol—Fatigue—Simvastatin—atherosclerosis	0.00188	0.00582	CcSEcCtD
Nebivolol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00187	0.00579	CcSEcCtD
Nebivolol—Urticaria—Lovastatin—atherosclerosis	0.00185	0.00574	CcSEcCtD
Nebivolol—Abdominal pain—Lovastatin—atherosclerosis	0.00184	0.00571	CcSEcCtD
Nebivolol—Dizziness—Rosuvastatin—atherosclerosis	0.00181	0.00564	CcSEcCtD
Nebivolol—Urticaria—Ezetimibe—atherosclerosis	0.00181	0.00563	CcSEcCtD
Nebivolol—Insomnia—Niacin—atherosclerosis	0.00181	0.00561	CcSEcCtD
Nebivolol—Abdominal pain—Ezetimibe—atherosclerosis	0.0018	0.0056	CcSEcCtD
Nebivolol—Paraesthesia—Niacin—atherosclerosis	0.00179	0.00557	CcSEcCtD
Nebivolol—Dyspnoea—Niacin—atherosclerosis	0.00178	0.00553	CcSEcCtD
Nebivolol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00178	0.00552	CcSEcCtD
Nebivolol—Insomnia—Pravastatin—atherosclerosis	0.00178	0.00552	CcSEcCtD
Nebivolol—Somnolence—Niacin—atherosclerosis	0.00178	0.00551	CcSEcCtD
Nebivolol—Paraesthesia—Pravastatin—atherosclerosis	0.00177	0.00548	CcSEcCtD
Nebivolol—Dyspnoea—Pravastatin—atherosclerosis	0.00175	0.00544	CcSEcCtD
Nebivolol—Rash—Rosuvastatin—atherosclerosis	0.00173	0.00537	CcSEcCtD
Nebivolol—Dermatitis—Rosuvastatin—atherosclerosis	0.00173	0.00537	CcSEcCtD
Nebivolol—Urticaria—Simvastatin—atherosclerosis	0.00173	0.00537	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Niacin—atherosclerosis	0.00172	0.00535	CcSEcCtD
Nebivolol—Abdominal pain—Simvastatin—atherosclerosis	0.00172	0.00534	CcSEcCtD
Nebivolol—Headache—Rosuvastatin—atherosclerosis	0.00172	0.00534	CcSEcCtD
Nebivolol—Hypersensitivity—Lovastatin—atherosclerosis	0.00171	0.00532	CcSEcCtD
Nebivolol—Fatigue—Pravastatin—atherosclerosis	0.0017	0.00527	CcSEcCtD
Nebivolol—Hypersensitivity—Ezetimibe—atherosclerosis	0.00168	0.00522	CcSEcCtD
Nebivolol—Asthenia—Lovastatin—atherosclerosis	0.00167	0.00518	CcSEcCtD
Nebivolol—Pruritus—Lovastatin—atherosclerosis	0.00165	0.00511	CcSEcCtD
Nebivolol—Asthenia—Ezetimibe—atherosclerosis	0.00164	0.00508	CcSEcCtD
Nebivolol—Gastrointestinal pain—Niacin—atherosclerosis	0.00163	0.00507	CcSEcCtD
Nebivolol—Nausea—Rosuvastatin—atherosclerosis	0.00163	0.00506	CcSEcCtD
Nebivolol—Pruritus—Ezetimibe—atherosclerosis	0.00161	0.00501	CcSEcCtD
Nebivolol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00161	0.00499	CcSEcCtD
Nebivolol—Hypersensitivity—Simvastatin—atherosclerosis	0.0016	0.00498	CcSEcCtD
Nebivolol—Diarrhoea—Lovastatin—atherosclerosis	0.00159	0.00494	CcSEcCtD
Nebivolol—Urticaria—Niacin—atherosclerosis	0.00159	0.00493	CcSEcCtD
Nebivolol—Abdominal pain—Niacin—atherosclerosis	0.00158	0.0049	CcSEcCtD
Nebivolol—Urticaria—Pravastatin—atherosclerosis	0.00156	0.00485	CcSEcCtD
Nebivolol—Asthenia—Simvastatin—atherosclerosis	0.00156	0.00485	CcSEcCtD
Nebivolol—Diarrhoea—Ezetimibe—atherosclerosis	0.00156	0.00485	CcSEcCtD
Nebivolol—Abdominal pain—Pravastatin—atherosclerosis	0.00155	0.00483	CcSEcCtD
Nebivolol—Pruritus—Simvastatin—atherosclerosis	0.00154	0.00478	CcSEcCtD
Nebivolol—Dizziness—Lovastatin—atherosclerosis	0.00154	0.00478	CcSEcCtD
Nebivolol—Dizziness—Ezetimibe—atherosclerosis	0.00151	0.00468	CcSEcCtD
Nebivolol—Diarrhoea—Simvastatin—atherosclerosis	0.00149	0.00462	CcSEcCtD
Nebivolol—Vomiting—Lovastatin—atherosclerosis	0.00148	0.00459	CcSEcCtD
Nebivolol—Hypersensitivity—Niacin—atherosclerosis	0.00147	0.00457	CcSEcCtD
Nebivolol—Rash—Lovastatin—atherosclerosis	0.00147	0.00455	CcSEcCtD
Nebivolol—Dermatitis—Lovastatin—atherosclerosis	0.00146	0.00455	CcSEcCtD
Nebivolol—Headache—Lovastatin—atherosclerosis	0.00146	0.00452	CcSEcCtD
Nebivolol—Vomiting—Ezetimibe—atherosclerosis	0.00145	0.0045	CcSEcCtD
Nebivolol—Hypersensitivity—Pravastatin—atherosclerosis	0.00145	0.0045	CcSEcCtD
Nebivolol—Dizziness—Simvastatin—atherosclerosis	0.00144	0.00447	CcSEcCtD
Nebivolol—Rash—Ezetimibe—atherosclerosis	0.00144	0.00447	CcSEcCtD
Nebivolol—Dermatitis—Ezetimibe—atherosclerosis	0.00144	0.00446	CcSEcCtD
Nebivolol—Asthenia—Niacin—atherosclerosis	0.00143	0.00445	CcSEcCtD
Nebivolol—Headache—Ezetimibe—atherosclerosis	0.00143	0.00444	CcSEcCtD
Nebivolol—Pruritus—Niacin—atherosclerosis	0.00141	0.00439	CcSEcCtD
Nebivolol—Asthenia—Pravastatin—atherosclerosis	0.00141	0.00438	CcSEcCtD
Nebivolol—Pruritus—Pravastatin—atherosclerosis	0.00139	0.00432	CcSEcCtD
Nebivolol—Vomiting—Simvastatin—atherosclerosis	0.00138	0.00429	CcSEcCtD
Nebivolol—Nausea—Lovastatin—atherosclerosis	0.00138	0.00429	CcSEcCtD
Nebivolol—Rash—Simvastatin—atherosclerosis	0.00137	0.00426	CcSEcCtD
Nebivolol—Dermatitis—Simvastatin—atherosclerosis	0.00137	0.00426	CcSEcCtD
Nebivolol—Diarrhoea—Niacin—atherosclerosis	0.00137	0.00424	CcSEcCtD
Nebivolol—Headache—Simvastatin—atherosclerosis	0.00136	0.00423	CcSEcCtD
Nebivolol—Nausea—Ezetimibe—atherosclerosis	0.00135	0.00421	CcSEcCtD
Nebivolol—Diarrhoea—Pravastatin—atherosclerosis	0.00135	0.00418	CcSEcCtD
Nebivolol—Dizziness—Niacin—atherosclerosis	0.00132	0.0041	CcSEcCtD
Nebivolol—Dizziness—Pravastatin—atherosclerosis	0.0013	0.00404	CcSEcCtD
Nebivolol—Nausea—Simvastatin—atherosclerosis	0.00129	0.00401	CcSEcCtD
Nebivolol—Vomiting—Niacin—atherosclerosis	0.00127	0.00394	CcSEcCtD
Nebivolol—Rash—Niacin—atherosclerosis	0.00126	0.00391	CcSEcCtD
Nebivolol—Dermatitis—Niacin—atherosclerosis	0.00126	0.00391	CcSEcCtD
Nebivolol—Headache—Niacin—atherosclerosis	0.00125	0.00389	CcSEcCtD
Nebivolol—Vomiting—Pravastatin—atherosclerosis	0.00125	0.00388	CcSEcCtD
Nebivolol—Rash—Pravastatin—atherosclerosis	0.00124	0.00385	CcSEcCtD
Nebivolol—Dermatitis—Pravastatin—atherosclerosis	0.00124	0.00385	CcSEcCtD
Nebivolol—Headache—Pravastatin—atherosclerosis	0.00123	0.00383	CcSEcCtD
Nebivolol—Nausea—Niacin—atherosclerosis	0.00119	0.00368	CcSEcCtD
Nebivolol—Nausea—Pravastatin—atherosclerosis	0.00117	0.00363	CcSEcCtD
Nebivolol—HTR1A—Signaling Pathways—CASR—atherosclerosis	6.09e-05	0.000817	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	6.05e-05	0.000812	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	6.01e-05	0.000806	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CX3CL1—atherosclerosis	5.98e-05	0.000801	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	5.92e-05	0.000794	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—EDN1—atherosclerosis	5.92e-05	0.000794	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	5.92e-05	0.000794	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	5.91e-05	0.000792	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CCL5—atherosclerosis	5.87e-05	0.000788	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	5.84e-05	0.000783	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	5.79e-05	0.000777	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	5.79e-05	0.000776	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	5.78e-05	0.000775	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	5.71e-05	0.000766	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CNR2—atherosclerosis	5.66e-05	0.00076	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—CXCL8—atherosclerosis	5.66e-05	0.000759	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MMP3—atherosclerosis	5.65e-05	0.000758	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	5.62e-05	0.000754	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PRKCG—atherosclerosis	5.58e-05	0.000749	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	5.58e-05	0.000748	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	5.5e-05	0.000737	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	5.45e-05	0.000732	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EDN1—atherosclerosis	5.38e-05	0.000721	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCL5—atherosclerosis	5.33e-05	0.000715	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	5.3e-05	0.000711	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	5.28e-05	0.000708	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	5.25e-05	0.000704	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	5.21e-05	0.000699	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	5.19e-05	0.000696	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	5.16e-05	0.000692	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	5.14e-05	0.000689	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCG1—atherosclerosis	5.14e-05	0.000689	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	5.13e-05	0.000688	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	5.1e-05	0.000684	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	5.09e-05	0.000683	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PRKCG—atherosclerosis	5.07e-05	0.00068	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VWF—atherosclerosis	5.05e-05	0.000677	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	5.02e-05	0.000674	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOC3—atherosclerosis	5.02e-05	0.000673	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LDLR—atherosclerosis	4.99e-05	0.000669	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	4.98e-05	0.000668	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AGT—atherosclerosis	4.91e-05	0.000659	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	4.88e-05	0.000654	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL3—atherosclerosis	4.87e-05	0.000653	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LCAT—atherosclerosis	4.83e-05	0.000648	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—FABP4—atherosclerosis	4.83e-05	0.000648	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	4.77e-05	0.00064	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	4.75e-05	0.000637	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA4—atherosclerosis	4.74e-05	0.000636	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	4.66e-05	0.000626	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NCF1—atherosclerosis	4.66e-05	0.000626	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP7A1—atherosclerosis	4.66e-05	0.000625	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	4.64e-05	0.000623	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	4.61e-05	0.000618	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	4.61e-05	0.000618	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	4.59e-05	0.000615	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	4.56e-05	0.000612	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	4.54e-05	0.000609	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—F2—atherosclerosis	4.54e-05	0.000609	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	4.51e-05	0.000604	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	4.51e-05	0.000604	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	4.49e-05	0.000602	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	4.49e-05	0.000602	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	4.49e-05	0.000602	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	4.49e-05	0.000602	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AGT—atherosclerosis	4.46e-05	0.000598	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	4.44e-05	0.000596	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EDNRA—atherosclerosis	4.41e-05	0.000591	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCR2—atherosclerosis	4.41e-05	0.000591	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	4.39e-05	0.000589	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	4.39e-05	0.000589	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	4.39e-05	0.000589	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CYBA—atherosclerosis	4.39e-05	0.000588	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	4.34e-05	0.000583	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	4.31e-05	0.000578	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	4.3e-05	0.000577	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PLAT—atherosclerosis	4.29e-05	0.000576	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PARP1—atherosclerosis	4.29e-05	0.000576	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GHRL—atherosclerosis	4.29e-05	0.000576	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	4.22e-05	0.000565	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	4.12e-05	0.000553	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—F2—atherosclerosis	4.12e-05	0.000553	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	4.08e-05	0.000547	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA2—atherosclerosis	4.08e-05	0.000547	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	4.08e-05	0.000547	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	4.08e-05	0.000547	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	4.03e-05	0.000541	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	4.03e-05	0.000541	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CG—atherosclerosis	3.95e-05	0.000529	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	3.94e-05	0.000528	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	3.92e-05	0.000525	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LPA—atherosclerosis	3.89e-05	0.000522	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	3.85e-05	0.000517	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	3.84e-05	0.000515	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	3.83e-05	0.000514	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	3.82e-05	0.000512	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—BGN—atherosclerosis	3.77e-05	0.000506	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KNG1—atherosclerosis	3.77e-05	0.000505	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	3.76e-05	0.000504	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGTR1—atherosclerosis	3.75e-05	0.000502	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	3.73e-05	0.000501	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA5—atherosclerosis	3.73e-05	0.000501	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCL2—atherosclerosis	3.67e-05	0.000493	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PLG—atherosclerosis	3.65e-05	0.00049	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	3.61e-05	0.000485	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	3.59e-05	0.000482	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	3.54e-05	0.000474	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	3.49e-05	0.000468	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	3.47e-05	0.000466	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	3.47e-05	0.000465	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SOCS3—atherosclerosis	3.46e-05	0.000464	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	3.41e-05	0.000458	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	3.4e-05	0.000456	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	3.37e-05	0.000452	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	3.34e-05	0.000449	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP3—atherosclerosis	3.34e-05	0.000448	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF2—atherosclerosis	3.32e-05	0.000446	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	3.32e-05	0.000445	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	3.3e-05	0.000443	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	3.29e-05	0.000442	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	3.27e-05	0.000439	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	3.25e-05	0.000436	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOB—atherosclerosis	3.23e-05	0.000433	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	3.22e-05	0.000432	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	3.22e-05	0.000432	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCL8—atherosclerosis	3.2e-05	0.000429	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EDN1—atherosclerosis	3.18e-05	0.000426	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL5—atherosclerosis	3.15e-05	0.000423	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	3.15e-05	0.000423	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	3.13e-05	0.00042	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	3.11e-05	0.000417	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LIPC—atherosclerosis	3.09e-05	0.000415	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LPL—atherosclerosis	3.08e-05	0.000413	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOC3—atherosclerosis	3.07e-05	0.000412	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	3.06e-05	0.000411	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LDLR—atherosclerosis	3.05e-05	0.00041	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	3.05e-05	0.000409	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	3.04e-05	0.000407	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	3e-05	0.000402	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	2.98e-05	0.0004	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CETP—atherosclerosis	2.98e-05	0.0004	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	2.97e-05	0.000398	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SPP1—atherosclerosis	2.92e-05	0.000391	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	2.91e-05	0.00039	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.86e-05	0.000383	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	2.82e-05	0.000379	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	2.76e-05	0.00037	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	2.76e-05	0.00037	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	2.7e-05	0.000362	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	2.7e-05	0.000362	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	2.7e-05	0.000362	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.7e-05	0.000362	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	2.7e-05	0.000362	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	2.68e-05	0.000359	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	2.67e-05	0.000358	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	2.64e-05	0.000354	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	2.64e-05	0.000354	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGT—atherosclerosis	2.64e-05	0.000353	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	2.62e-05	0.000351	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	2.61e-05	0.00035	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LEP—atherosclerosis	2.58e-05	0.000346	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOE—atherosclerosis	2.58e-05	0.000346	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	2.58e-05	0.000346	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CAV1—atherosclerosis	2.56e-05	0.000343	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOA1—atherosclerosis	2.55e-05	0.000342	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—F2—atherosclerosis	2.55e-05	0.000341	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	2.52e-05	0.000338	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—F2—atherosclerosis	2.49e-05	0.000334	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ESR1—atherosclerosis	2.47e-05	0.000331	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	2.44e-05	0.000327	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—F2—atherosclerosis	2.44e-05	0.000327	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.4e-05	0.000323	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	2.38e-05	0.00032	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	2.33e-05	0.000313	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	2.33e-05	0.000313	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—INS—atherosclerosis	2.31e-05	0.000309	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	2.28e-05	0.000306	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	2.27e-05	0.000304	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—INS—atherosclerosis	2.26e-05	0.000303	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	2.23e-05	0.000299	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	2.23e-05	0.000299	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	2.22e-05	0.000298	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—INS—atherosclerosis	2.21e-05	0.000296	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	2.18e-05	0.000293	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL2—atherosclerosis	2.17e-05	0.000291	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1—atherosclerosis	2.13e-05	0.000286	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	2.12e-05	0.000284	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	2.07e-05	0.000278	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.06e-05	0.000277	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	2.03e-05	0.000272	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	2.02e-05	0.000271	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.98e-05	0.000265	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOB—atherosclerosis	1.98e-05	0.000265	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOS3—atherosclerosis	1.93e-05	0.000259	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.92e-05	0.000258	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LPL—atherosclerosis	1.89e-05	0.000253	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GPX1—atherosclerosis	1.84e-05	0.000247	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	1.79e-05	0.000241	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CD36—atherosclerosis	1.79e-05	0.00024	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	1.76e-05	0.000235	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	1.73e-05	0.000232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	1.72e-05	0.00023	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	1.71e-05	0.000229	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.7e-05	0.000228	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	1.7e-05	0.000227	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	1.67e-05	0.000224	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARA—atherosclerosis	1.67e-05	0.000224	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	1.66e-05	0.000222	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—atherosclerosis	1.63e-05	0.000219	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	1.62e-05	0.000218	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AGT—atherosclerosis	1.61e-05	0.000217	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	1.61e-05	0.000215	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	1.59e-05	0.000213	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOE—atherosclerosis	1.58e-05	0.000212	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	1.58e-05	0.000212	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	1.57e-05	0.000211	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	1.57e-05	0.000211	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CAV1—atherosclerosis	1.57e-05	0.00021	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA1—atherosclerosis	1.56e-05	0.00021	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—atherosclerosis	1.55e-05	0.000208	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	1.54e-05	0.000207	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	1.54e-05	0.000206	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	1.54e-05	0.000206	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	1.51e-05	0.000202	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	1.51e-05	0.000202	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	1.46e-05	0.000195	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	1.44e-05	0.000194	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.43e-05	0.000191	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	1.43e-05	0.000191	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	1.41e-05	0.000189	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	1.39e-05	0.000187	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STAT3—atherosclerosis	1.38e-05	0.000185	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	1.38e-05	0.000185	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARG—atherosclerosis	1.38e-05	0.000185	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—INS—atherosclerosis	1.35e-05	0.000181	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	1.35e-05	0.000181	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	1.34e-05	0.000179	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	1.32e-05	0.000177	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	1.31e-05	0.000175	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	1.28e-05	0.000172	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—atherosclerosis	1.24e-05	0.000166	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NOS3—atherosclerosis	1.19e-05	0.000159	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.08e-05	0.000145	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	1.01e-05	0.000135	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	9.86e-06	0.000132	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—atherosclerosis	9.64e-06	0.000129	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	9.3e-06	0.000125	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	9.1e-06	0.000122	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—atherosclerosis	8.89e-06	0.000119	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—atherosclerosis	5.45e-06	7.31e-05	CbGpPWpGaD
